Digest Network Come funziona
Network
/
Società
Qu
Non verificato

QurAlis Corporation

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaMedicina - VarieSalute

12 comunicati stampa

Guarda tutti i comunicati
24/08/2026
Eventi
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
QurAlis to Participate in Upcoming Investor Conferences in September
Fonte
QurAlis Corporation
Emittente
Business Wire
1.00
0
23/02/2026
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
QurAlis Demonstrates Effects on Disease Progression and Target Engagement in ANQUR Clinical Trial of QRL-201, a First-in-Class Precision Medicine in Development for Sporadic ALS
Fonte
QurAlis Corporation
Emittente
Business Wire
1.00
0
23/02/2026
Industria
Salute
Medicina - Varie
Sanità
Farmaceutica
Biotecnologia
QurAlis Demonstrates Effects on Disease Progression and Target Engagement in ANQUR Clinical Trial of QRL-201, a First-in-Class Precision Medicine in Development for Sporadic ALS
Fonte
QurAlis Corporation
Emittente
Business Wire
1.00
0
29/12/2026
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
QurAlis Confirms Signal of Target Engagement in ALS Patients in Phase 1 Clinical Trial of QRL-101, a Potentially Best-in-Class Selective Kv7.2/7.3 Ion Channel Opener
Fonte
QurAlis Corporation
Emittente
Business Wire
1.00
0
18/12/2025
Eventi
Web e Social Network
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
QurAlis Invited to Present at 44th Annual J.P. Morgan Healthcare Conference
Fonte
QurAlis Corporation
Emittente
Business Wire
1.00
0
02/12/2025
Biotecnologia
Farmaceutica
Salute
QurAlis to Present Data From its Phase 1 Clinical Trial of QRL-101, a Potential Best-in-Class Selective Kv7.2/7.3 Ion Channel Opener, at American Epilepsy Society 2025 Annual Meeting
Fonte
QurAlis Corporation
Emittente
Business Wire
1.00
0
20/11/2025
Biotecnologia
Sanità
Salute
Farmaceutica
Web e Social Network
Fiere
Eventi
QurAlis to Participate in Piper Sandler 37th Annual Healthcare Conference
Fonte
QurAlis Corporation
Emittente
Business Wire
1.00
0
10/11/2025
QurAlis Announces Appointment of Manoj Malhotra, M.D., as Chief Medical Officer
Fonte
QurAlis Corporation
Emittente
Business Wire
1.00
0
03/11/2025
Scienza
Biotecnologia
Farmaceutica
Sanità
Salute
Eventi
Fiere
QurAlis to Participate in Upcoming Investor Conferences in November
Fonte
QurAlis Corporation
Emittente
Business Wire
1.00
0
20/08/2025
Biotecnologia
Farmaceutica
Salute
Eventi
QurAlis to Participate in Upcoming Investor Conferences in September
Fonte
QurAlis Corporation
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0